ESR1 and breast cancer: In addition, estrogen receptor-α (ERα)-negative human breast cancer MDA-MB-231 cells (MDA-MB) were treated with 7 different concentrations of tetrac (10−8 to 10−5 M) for 19 d and total cell counts determined every 1–2 d (Fig. 3B).